Larvol Delta - Annovis-Bio-Announces-Positive-FDA-Notice-For-Buntanetap-Phase-3-Clinical-Trial-In-Parkinson39s-Disease

Posiphen (buntanetap) - Annovis Bio

https://www.prnewswire.com/news-releases/annovis-bio-announces-positive-fda-notice-for-buntanetap-phase-3-clinical-trial-in-parkinsons-disease-301582101.html

Jul 7, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next